GSE59515
Breat cancer dataset (J Clin Oncol 2015, 75 patients)
| clinical response | gender | patient id | time point | tissue | |
|---|---|---|---|---|---|
| GSM1438585 | Non-responder | Female | 150 | pre-treatment | tumour biopsies |
| GSM1438586 | Non-responder | Female | 150 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438587 | Non-responder | Female | 150 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438588 | Responder | Female | 171 | pre-treatment | tumour biopsies |
| GSM1438589 | Responder | Female | 171 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438590 | Responder | Female | 171 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438591 | Responder | Female | 172 | pre-treatment | tumour biopsies |
| GSM1438592 | Responder | Female | 172 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438593 | Responder | Female | 172 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438594 | Non-responder | Female | 179 | pre-treatment | tumour biopsies |
| GSM1438595 | Non-responder | Female | 179 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438596 | Non-responder | Female | 179 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438597 | Non-responder | Female | 203 | pre-treatment | tumour biopsies |
| GSM1438598 | Non-responder | Female | 203 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438599 | Non-responder | Female | 203 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438600 | Non-responder | Female | 214 | pre-treatment | tumour biopsies |
| GSM1438601 | Non-responder | Female | 214 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438602 | Non-responder | Female | 214 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438603 | Responder | Female | 215 | pre-treatment | tumour biopsies |
| GSM1438604 | Responder | Female | 215 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438605 | Responder | Female | 215 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438606 | Responder | Female | 226 | pre-treatment | tumour biopsies |
| GSM1438607 | Responder | Female | 226 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438608 | Responder | Female | 226 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438609 | Responder | Female | 269 | pre-treatment | tumour biopsies |
| GSM1438610 | Responder | Female | 269 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438611 | Responder | Female | 269 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438612 | Responder | Female | 300 | pre-treatment | tumour biopsies |
| GSM1438613 | Responder | Female | 300 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438614 | Responder | Female | 300 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438615 | Responder | Female | 311 | pre-treatment | tumour biopsies |
| GSM1438616 | Responder | Female | 311 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438617 | Responder | Female | 311 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438618 | Responder | Female | 328 | pre-treatment | tumour biopsies |
| GSM1438619 | Responder | Female | 328 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438620 | Responder | Female | 328 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438621 | Responder | Female | 329 | pre-treatment | tumour biopsies |
| GSM1438622 | Responder | Female | 329 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438623 | Responder | Female | 329 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438624 | Non-responder | Female | 331 | pre-treatment | tumour biopsies |
| GSM1438625 | Non-responder | Female | 331 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438626 | Non-responder | Female | 331 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438627 | Responder | Female | 332 | pre-treatment | tumour biopsies |
| GSM1438628 | Responder | Female | 332 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438629 | Responder | Female | 332 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438630 | Responder | Female | 340 | pre-treatment | tumour biopsies |
| GSM1438631 | Responder | Female | 340 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438632 | Responder | Female | 340 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438633 | Responder | Female | 341 | pre-treatment | tumour biopsies |
| GSM1438634 | Responder | Female | 341 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438635 | Responder | Female | 341 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438636 | Responder | Female | 346 | pre-treatment | tumour biopsies |
| GSM1438637 | Responder | Female | 346 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438638 | Responder | Female | 346 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438639 | Responder | Female | 355 | pre-treatment | tumour biopsies |
| GSM1438640 | Responder | Female | 355 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438641 | Responder | Female | 355 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438642 | Responder | Female | 357 | pre-treatment | tumour biopsies |
| GSM1438643 | Responder | Female | 357 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438644 | Responder | Female | 357 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438645 | Non-responder | Female | 363 | pre-treatment | tumour biopsies |
| GSM1438646 | Non-responder | Female | 363 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438647 | Non-responder | Female | 363 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438648 | Non-responder | Female | 364 | pre-treatment | tumour biopsies |
| GSM1438649 | Non-responder | Female | 364 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438650 | Non-responder | Female | 364 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438651 | Non-responder | Female | 367 | pre-treatment | tumour biopsies |
| GSM1438652 | Non-responder | Female | 367 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438653 | Non-responder | Female | 367 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438654 | Responder | Female | 369 | pre-treatment | tumour biopsies |
| GSM1438655 | Responder | Female | 369 | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438656 | Responder | Female | 369 | 3 months of letrozole treatment | tumour biopsies |
| GSM1438657 | Responder | Female | 373R | pre-treatment | tumour biopsies |
| GSM1438658 | Responder | Female | 373R | 2 wks of letrozole treatment | tumour biopsies |
| GSM1438659 | Responder | Female | 373R | 3 months of letrozole treatment | tumour biopsies |